Chesapeake Capital Corp’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
9,736
+764
+9% +$89.4K 0.66% 37
2026
Q1
$1.08M Buy
8,972
+262
+3% +$30.2K 0.78% 35
2025
Q4
$917K Buy
+8,710
New +$818K 0.77% 41

Other funds holding MRK

Chesapeake Capital Corp's MRK Position: Q2 2026 in Review

Chesapeake Capital Corp increased its Merck (MRK) stake by 8.5% in Q2 2026, buying an estimated $89.4K and bringing the position to 9,736 shares worth $1.25M. The position accounts for 0.66% of the portfolio, ranked #37.

Chesapeake Capital Corp first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Chesapeake Capital Corp held 9,736 shares of Merck worth $1.25M as of Q2 2026.
  • Chesapeake Capital Corp bought 764 Merck shares in Q2 2026, an estimated $89.4K.
  • Merck made up 0.66% of Chesapeake Capital Corp's portfolio in Q2 2026, its #37 holding.
  • Chesapeake Capital Corp first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.